Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
8
×
national blog main
startups
8
×
life sciences
san francisco blog main
biotech
boston blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco top stories
clinical trials
deals
drugs
investing
new york top stories
raleigh-durham blog main
texas blog main
texas top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
national
nonalcoholic steatohepatitis
raleigh-durham top stories
san francisco
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
What
drug
8
×
therapeutics
disease
roundup
annual
attention
bio
biotech
digital
latest
medicines
momentum
news
therapy
ahead
alzheimer’s
ambien
american
announced
approved
asco
assessed
attendees
backs
bacteria
based
bets
big
biopharma
building
business
camp’s
cancer
candidate
cash
catch
chicago
city
click
clinical
Language
Current search:
startups
×
drug
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
